“…Highly sensitive and specific THz metamaterial biosensors were also fabricated for cancer detection [144], pancreatic cancer biomarker called exosomal microRNA with high accuracy [154], CA125 and CA199 cancer biomarkers [155], type A549 lung cancer cells [156], carcinoma cells [157], [158], [159], [160], skin cancer [114], [161], breast cancer [162], [163], colon cancer [164]. Plasmon based metamaterial biosensors that use Graphene were also proposed that are a breakthrough invention due to being highly sensitive, low cost prototyping, fabrication, design and inherent configurability [151], [165], [166], [167], [168], [169], [170].…”